Michael Arand

9.9k total citations · 2 hit papers
112 papers, 7.8k citations indexed

About

Michael Arand is a scholar working on Molecular Biology, Pharmacology and Biochemistry. According to data from OpenAlex, Michael Arand has authored 112 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 43 papers in Pharmacology and 39 papers in Biochemistry. Recurrent topics in Michael Arand's work include Pharmacogenetics and Drug Metabolism (40 papers), Eicosanoids and Hypertension Pharmacology (34 papers) and Biochemical Acid Research Studies (18 papers). Michael Arand is often cited by papers focused on Pharmacogenetics and Drug Metabolism (40 papers), Eicosanoids and Hypertension Pharmacology (34 papers) and Biochemical Acid Research Studies (18 papers). Michael Arand collaborates with scholars based in Germany, Switzerland and United States. Michael Arand's co-authors include Franz Oesch, Julia Karbach, Alexander Knuth, Elke Jäger, Lloyd J. Old, Elisabeth Stockert, Mark Ringhoffer, Annette Cronin, Yao‐Tseng Chen and Jan G. Hengstler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Michael Arand

111 papers receiving 7.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes

1998 594 citations Elke Jäger, Julia Karbach et al. The Journal of Experimental Medicine profile →
A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens

1998 593 citations Elisabeth Stockert, Elke Jäger et al. The Journal of Experimental Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Michael Arand	4.1k	3.1k	1.5k	1.3k	1.0k	112	7.8k
Abraham Novogrodsky	3.0k 0.7×	1.5k 0.5×	614 0.4×	676 0.5×	173 0.2×	155	5.9k
Wayne B. Anderson	6.6k 1.6×	945 0.3×	731 0.5×	475 0.4×	200 0.2×	150	9.1k
Masayoshi Imagawa	6.3k 1.6×	1.1k 0.4×	1.1k 0.8×	460 0.3×	205 0.2×	157	9.3k
Mark Hannink	6.6k 1.6×	1.2k 0.4×	739 0.5×	373 0.3×	211 0.2×	92	9.0k
Hideaki Kamata	4.1k 1.0×	1.4k 0.5×	917 0.6×	289 0.2×	306 0.3×	71	6.8k
David Gius	8.0k 2.0×	1.0k 0.3×	1.6k 1.1×	417 0.3×	156 0.2×	148	13.7k
Hans R. Waterham	12.8k 3.1×	1.6k 0.5×	1.1k 0.7×	1.3k 1.0×	169 0.2×	300	15.8k
Nika N. Danial	7.2k 1.8×	1.5k 0.5×	1.5k 1.0×	244 0.2×	194 0.2×	56	10.4k
Stephen J. Ralph	3.9k 1.0×	1.6k 0.5×	1.6k 1.1×	217 0.2×	178 0.2×	101	6.9k
David T. Dudley	5.6k 1.4×	1.1k 0.4×	1.6k 1.1×	230 0.2×	191 0.2×	39	8.6k

Countries citing papers authored by Michael Arand

Since Specialization

Citations

This map shows the geographic impact of Michael Arand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Arand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Arand more than expected).

Fields of papers citing papers by Michael Arand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Arand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Arand. The network helps show where Michael Arand may publish in the future.

Co-authorship network of co-authors of Michael Arand

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Arand. A scholar is included among the top collaborators of Michael Arand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Arand. Michael Arand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Looser, Zoe J., Tal Laviv, Jean‐Charles Paterna, et al.. (2025). Abundance-biased codon diversification prevents recombination in AAV production and ensures robust in vivo expression of functional FRET sensors. Communications Biology. 8(1). 1244–1244.

Rodríguez-Pérez, Raquel, Birk Poller, Felix Huth, et al.. (2024). Drug-induced cholestasis (DIC) predictions based on in vitro inhibition of major bile acid clearance mechanisms. Archives of Toxicology. 99(1). 377–391. 2 indexed citations

Deán‐Ben, Xosé Luís, Justine Robin, Ruiqing Ni, et al.. (2023). Deep optoacoustic localization microangiography of ischemic stroke in mice. Nature Communications. 14(1). 3584–3584. 36 indexed citations

Hartwig, A., Michael Arand, Bernd Epe, et al.. (2020). Mode of action-based risk assessment of genotoxic carcinogens. Archives of Toxicology. 94(6). 1787–1877. 100 indexed citations

Madacki, Jan, Françoise Laval, Anna E. Grzegorzewicz, et al.. (2018). Impact of the epoxide hydrolase EphD on the metabolism of mycolic acids in mycobacteria. Journal of Biological Chemistry. 293(14). 5172–5184. 20 indexed citations

Marowsky, Anne, et al.. (2009). Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism. Neuroscience. 163(2). 646–661. 101 indexed citations

Greim, Helmut, Michael Arand, Herman Autrup, et al.. (2006). Toxicological comments to the discussion about REACH. Archives of Toxicology. 80(3). 121–124. 35 indexed citations

Adamska, Magdalena, Michael Arand, Jürg A. Zarn, et al.. (2006). Comparison of lanosterol-14α-demethylase (CYP51) of human and Candida albicans for inhibition by different antifungal azoles. Toxicology. 228(1). 24–32. 78 indexed citations

Johansson, Patrik, Torsten Unge, Annette Cronin, et al.. (2005). Structure of an Atypical Epoxide Hydrolase from Mycobacterium tuberculosis Gives Insights into its Function. Journal of Molecular Biology. 351(5). 1048–1056. 39 indexed citations

10.

Jäger, Elke, Julia Karbach, Sacha Gnjatic, et al.. (2002). Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51. PubMed. 2. 12–12. 28 indexed citations

11.

Jäger, Elke, Dirk Jäger, Julia Karbach, et al.. (2000). Identification of Ny-Eso-1 Epitopes Presented by Human Histocompatibility Antigen (Hla)-Drb4*0101–0103 and Recognized by Cd4+T Lymphocytes of Patients with Ny-Eso-1–Expressing Melanoma. The Journal of Experimental Medicine. 191(4). 625–630. 186 indexed citations

12.

Hengstler, Jan G., Nadja Dornhöfer, Rolf Meinert, et al.. (1999). Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer. PubMed. 59(13). 3206–14. 87 indexed citations

13.

Arand, Michael, Heike Dürk, J. Baratti, et al.. (1999). Cloning and molecular characterization of a soluble epoxide hydrolase from Aspergillus niger that is related to mammalian microsomal epoxide hydrolase. Biochemical Journal. 344(1). 273–273. 81 indexed citations

14.

Hengstler, Jan G., et al.. (1998). Polymorphisms of N-Acetyltransferases, Glutathione S-Transferases, Microsomal Epoxide Hydrolase and Sulfotransferases: Influence on Cancer Susceptibility. Recent results in cancer research. 154. 47–85. 191 indexed citations

15.

Müller, Frank, Michael Arand, Heinz Frank, et al.. (1997). Visualization of a Covalent Intermediate between Microsomal Epoxide Hydrolase, but not Cholesterol Epoxide Hydrolase, and their Substrates. European Journal of Biochemistry. 245(2). 490–496. 50 indexed citations

16.

Jaeger, E., Helga Bernhard, Pedro Romero, et al.. (1996). Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptidesin vivo: Implications for tumor vaccines with melanoma-associated antigens. International Journal of Cancer. 66(2). 162–169. 195 indexed citations

17.

Härtter, Sebastian, Christoph Hiemke, Michael Arand, & Franz Oesch. (1995). Non-competitive inhibition of clomipramineN-demethylation by fluvoxamine. Psychopharmacology. 117(2). 149–153. 17 indexed citations

18.

Oesch, Franz, et al.. (1995). Detection of primary DNA damage: applicability to biomonitoring of genotoxic occupational exposure and in clinical therapy. Pharmacogenetics. 5(Special Issue). S118–S122. 13 indexed citations

19.

Diener, Bernd, Michael Arand, J. Leißner, et al.. (1994). Xenobiotic metabolizing enzyme activities in isolated and cryopreserved human liver parenchymal cells. Toxicology in Vitro. 8(6). 1161–1166. 15 indexed citations

20.

Arand, Michael, et al.. (1991). An impaired peroxisomal targeting sequence leading to an unusual bicompartmental distribution of cytosolic epoxide hydrolase. FEBS Letters. 294(1-2). 19–22. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact